Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Assets (2016 - 2025)

Historic Return on Assets for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to 0.19%.

  • Ptc Therapeutics' Return on Assets rose 4700.0% to 0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year increase of 4700.0%. This contributed to the annual value of 0.35% for FY2024, which is 500.0% up from last year.
  • Ptc Therapeutics' Return on Assets amounted to 0.19% in Q3 2025, which was up 4700.0% from 0.14% recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Return on Assets registered a high of 0.19% during Q3 2025, and its lowest value of 0.5% during Q3 2023.
  • Its 5-year average for Return on Assets is 0.25%, with a median of 0.31% in 2024.
  • As far as peak fluctuations go, Ptc Therapeutics' Return on Assets plummeted by -1800bps in 2023, and later soared by 5100bps in 2025.
  • Over the past 5 years, Ptc Therapeutics' Return on Assets (Quarter) stood at 0.27% in 2021, then decreased by -29bps to 0.34% in 2022, then crashed by -32bps to 0.45% in 2023, then increased by 22bps to 0.35% in 2024, then skyrocketed by 153bps to 0.19% in 2025.
  • Its last three reported values are 0.19% in Q3 2025, 0.14% for Q2 2025, and 0.15% during Q1 2025.